Department of Internal Medicine, Yaounde Faculty of Medicine and Biomedical Sciences, Yaounde, Cameroon; Department of Medicine, University of Cape Town, Cape Town, South Africa; Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Division of Nephrology and Hypertension, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
Glob Heart. 2018 Mar;13(1):45-59. doi: 10.1016/j.gheart.2017.06.001. Epub 2017 Oct 16.
The Pan-African Society of Cardiology (PASCAR) has identified hypertension as the highest area of priority action to reduce heart disease and stroke on the continent.
The aim of this PASCAR roadmap on hypertension was to develop practical guidance on how to implement strategies that translate existing knowledge into effective action and improve detection, treatment and control of hypertension and cardiovascular health in sub-Saharan Africa (SSA) by the year 2025.
Development of this roadmap started with the creation of a consortium of experts with leadership skills in hypertension. In 2014, experts in different fields, including physicians and nonphysicians, were invited to join. Via face-to-face meetings and teleconferences, the consortium made a situation analysis, set a goal, identified roadblocks and solutions to the management of hypertension and customized the World Heart Federation roadmap to Africa.
Hypertension is a major crisis on the continent but very few randomized controlled trials have been conducted on its management. Also, only 25.8% of the countries have developed or adopted guidelines for management of hypertension. Other major roadblocks are either government and health-system related or health care professional or patient related. The PASCAR hypertension task force identified a 10-point action plan to be implemented by African ministries of health to achieve 25% control of hypertension in Africa by 2025.
Hypertension affects millions of people in SSA and if left untreated, is a major cause of heart disease and stroke. Very few SSA countries have a clear hypertension policy. This PASCAR roadmap identifies practical and effective solutions that would improve detection, treatment and control of hypertension on the continent and could be implemented as is or adapted to specific national settings.
泛非心脏病学会（PASCAR）已将高血压确定为降低非洲大陆心脏病和中风发病率的首要行动领域。
本学会高血压路线图旨在制定实用指南，说明如何实施各项战略，将现有知识转化为有效行动，提高撒哈拉以南非洲（SSA）地区高血压和心血管健康的检出率、治疗率和控制率，目标是在 2025 年实现这一目标。
该路线图的制定工作首先成立了一个高血压专家领导小组，邀请具有高血压领导能力的专家参与。2014 年，邀请了包括医生和非医生在内的不同领域的专家加入。通过面对面会议和电话会议，专家组进行了情况分析，确定了目标，找出了高血压管理方面的障碍和解决方案，并对世界心脏联合会的非洲路线图进行了定制。
高血压是非洲大陆的一个主要危机，但对其管理的随机对照试验很少。此外，只有 25.8%的国家制定或采用了高血压管理指南。其他主要障碍要么与政府和卫生系统有关，要么与医疗保健专业人员或患者有关。PASCAR 高血压工作组确定了一项 10 点行动计划，由非洲各国卫生部实施，以实现到 2025 年将非洲高血压控制率提高 25%的目标。
高血压影响着 SSA 的数百万人，如果不加以治疗，将是心脏病和中风的主要病因。很少有 SSA 国家有明确的高血压政策。本 PASCAR 路线图确定了实用且有效的解决方案，将提高该大陆高血压的检出率、治疗率和控制率，可直接实施或根据具体国情进行调整。
